Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
TTK HEALTHCARE TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
TTK HEALTHCARE Mar-23 |
TEVA PHARMA Dec-13 |
TTK HEALTHCARE/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,106 | 3,480 | - | |
Low | Rs | 668 | 3,023 | - | |
Sales per share (Unadj.) | Rs | 513.2 | 1,997.4 | - | |
Earnings per share (Unadj.) | Rs | 31.6 | 124.8 | - | |
Cash flow per share (Unadj.) | Rs | 40.7 | 286.2 | - | |
Dividends per share (Unadj.) | Rs | 10.00 | 109.23 | - | |
Avg Dividend yield | % | 1.1 | 3.4 | 33.6% | |
Book value per share (Unadj.) | Rs | 674.7 | 2,218.7 | - | |
Shares outstanding (eoy) | m | 14.13 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.7 | 1.6 | 106.1% | |
Avg P/E ratio | x | 28.0 | 26.1 | 107.6% | |
P/CF ratio (eoy) | x | 21.8 | 11.4 | 191.9% | |
Price / Book Value ratio | x | 1.3 | 1.5 | 89.7% | |
Dividend payout | % | 31.6 | 87.5 | 36.1% | |
Avg Mkt Cap | Rs m | 12,529 | 2,757,543 | 0.5% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 1,234 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,685.6 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,354.2 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 7,251 | 1,693,781 | 0.4% | |
Other income | Rs m | 483 | 0 | - | |
Total revenues | Rs m | 7,734 | 1,693,781 | 0.5% | |
Gross profit | Rs m | 313 | 463,843 | 0.1% | |
Depreciation | Rs m | 128 | 136,910 | 0.1% | |
Interest | Rs m | 52 | 33,269 | 0.2% | |
Profit before tax | Rs m | 616 | 293,664 | 0.2% | |
Minority Interest | Rs m | 0 | 1,334 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,775 | -0.0% | |
Tax | Rs m | 170 | -3,585 | -4.7% | |
Profit after tax | Rs m | 447 | 105,809 | 0.4% | |
Gross profit margin | % | 4.3 | 27.4 | 15.8% | |
Effective tax rate | % | 27.5 | -1.2 | -2,254.8% | |
Net profit margin | % | 6.2 | 6.2 | 98.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 10,664 | 1,143,974 | 0.9% | |
Current liabilities | Rs m | 2,108 | 997,642 | 0.2% | |
Net working cap to sales | % | 118.0 | 8.6 | 1,365.8% | |
Current ratio | x | 5.1 | 1.1 | 441.2% | |
Inventory Days | Days | 13 | 91 | 14.1% | |
Debtors Days | Days | 464 | 96 | 483.4% | |
Net fixed assets | Rs m | 994 | 553,226 | 0.2% | |
Share capital | Rs m | 141 | 4,169 | 3.4% | |
Net worth | Rs m | 9,534 | 1,881,470 | 0.5% | |
Long term debt | Rs m | 0 | 866,068 | 0.0% | |
Total assets | Rs m | 11,658 | 3,870,833 | 0.3% | |
Interest coverage | x | 12.8 | 9.8 | 129.9% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.4 | 142.1% | |
Return on assets | % | 4.3 | 3.6 | 119.2% | |
Return on equity | % | 4.7 | 5.6 | 83.3% | |
Return on capital | % | 7.0 | 4.9 | 142.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -261 | 269,901 | -0.1% | |
From Investments | Rs m | 330 | -95,637 | -0.3% | |
From Financial Activity | Rs m | -124 | -323,765 | 0.0% | |
Net Cashflow | Rs m | -55 | -149,500 | 0.0% |
Compare TTK HEALTHCARE With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare TTK HEALTHCARE With: SUN PHARMA PFIZER KIMIA BIOSCIENCES SYNCOM FORMULATIONS VIVIMED LABS
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.